Page last updated: 2024-11-13

ascorbyl monolaurate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID54702628
CHEMBL ID219802
SCHEMBL ID1762406
MeSH IDM0049273

Synonyms (26)

Synonym
CHEMBL219802
unii-fm8s1o02og
l-ascorbic acid, 6-dodecanoate
fm8s1o02og ,
16690-40-7
ascorbyl monolaurate
6-o-lauryl-1-ascorbic acid
ascorbyl laurate
lauric acid, 6-ester with l-ascorbic acid
l-ascorbyl 6-laurate
l-ascorbyl laurate
l-6-monolauroylascorbic acid
l-ascorbic acid, 6-laurate
SCHEMBL1762406
DWKSHXDVQRZSII-SUMWQHHRSA-N
ascorbic acid 6-laurate
l-ascorbyl dodecanoate
dodecanoic acid (s)-2-((r)-3,4-dihydroxy-5-oxo-2,5-dihydro-furan-2-yl)-2-hydroxy-ethyl ester
6-o-lauroyl-l-ascorbic acid
6-o-dodecanoylhex-1-enofuranos-3-ulose
DTXSID50937256
Q27278079
(s)-2-((r)-3,4-dihydroxy-5-oxo-2,5-dihydrofuran-2-yl)-2-hydroxyethyl dodecanoate
[(2s)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethyl] dodecanoate
6-o-dodecanoyl-l-ascorbic acid
E98840

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The incorporation of AZM in coagels seems to improve the ocular bioavailability of this drug."( Improvement of acetazolamide ocular permeation using ascorbyl laurate nanostructures as drug delivery system.
Allemandi, DA; Palma, SD; Quinteros, DA; Saino, V; Tártara, LI, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID274155Inhibition of Streptococcus agalactiae 4755 hyaluronidase at pH 5.02006Bioorganic & medicinal chemistry letters, Oct-15, Volume: 16, Issue:20
Novel 6-O-acylated vitamin C derivatives as hyaluronidase inhibitors with selectivity for bacterial lyases.
AID274156Inhibition of bovine hyaluronidase at pH 5.02006Bioorganic & medicinal chemistry letters, Oct-15, Volume: 16, Issue:20
Novel 6-O-acylated vitamin C derivatives as hyaluronidase inhibitors with selectivity for bacterial lyases.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.84

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.84 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.84)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]